Phase 2 Study of MGL-3196 in Patients With Non-Alcoholic Steatohepatitis (NASH)
Public ClinicalTrials.gov record NCT02912260. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2, Multi-Center, Double-Blind, Randomized, Placebo-controlled Study of MGL-3196 in Patients With Non-alcoholic Steatohepatitis
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The primary objective of this study is to determine the effect of once-daily oral MGL-3196 on the percent change in hepatic fat fraction from baseline in participants with biopsy-proven Non-alcoholic Steatohepatitis (NASH).
Study identification
- NCT ID
- NCT02912260
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 125 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 18, 2016 (Actual)
- Primary completion
- Oct 25, 2017 (Actual)
- Completion
- Nov 23, 2021 (Actual)
- Last update posted
- Dec 23, 2025
2016 – 2021
United States locations
- U.S. sites
- 26
- U.S. states
- 17
- U.S. cities
- 26
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Madrigal Research Site | Dothan | Alabama | — | — |
| Madrigal Research Site | Tucson | Arizona | — | — |
| Madrigal Research Site | Coronado | California | — | — |
| Madrigal Research Site | Los Angeles | California | 90057 | — |
| Madrigal Research Site | Rialto | California | — | — |
| Madrigal Research Site | San Diego | California | — | — |
| Madrigal Research Site | Ventura | California | — | — |
| Madrigal Research Site | Englewood | Colorado | — | — |
| Madrigal Research Site | Boca Raton | Florida | — | — |
| Madrigal Research Site | Lakewood Rch | Florida | — | — |
| Madrigal Research Site | Lauderdale Lakes | Florida | — | — |
| Madrigal Research Site | Miami | Florida | — | — |
| Madrigal Research Site | New Port Richey | Florida | — | — |
| Madrigal Research Site | Kansas City | Kansas | — | — |
| Madrigal Research Site | Monroe | Louisiana | — | — |
| Madrigal Research Site | Baltimore | Maryland | — | — |
| Madrigal Research Site | Jackson | Mississippi | 39202 | — |
| Madrigal Research Site | St Louis | Missouri | — | — |
| Madrigal Research Site | Albuquerque | New Mexico | — | — |
| Madrigal Research Site | New York | New York | — | — |
| Madrigal Research Site | Durham | North Carolina | — | — |
| Madrigal Research Site | Rapid City | South Dakota | — | — |
| Madrigal Research Site | Live Oak | Texas | 78233 | — |
| Madrigal Research Site | San Antonio | Texas | — | — |
| Madrigal Research Site | Charlottesville | Virginia | — | — |
| Madrigal Research Site | Seattle | Washington | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02912260, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 23, 2025 · Synced Oct 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02912260 live on ClinicalTrials.gov.